GL Ventures, Temasek co-lead $230m round in China's Clover Biopharmaceuticals

Clover Biopharmaceuticals, a global clinical-stage biotech company that develops and commercialises transformative biologic therapies, announced on Tuesday the completion of an oversubscribed Series C funding round at $230 million.